Company profile OMER
There is not enough data for Omeros biopharmaceutical to provide analysis
There is not enough data for Omeros biopharmaceutical to provide correlation calculation
There is not enough data for Omeros biopharmaceutical to provide analysis
After 34 days of this quarter the interest is at 48.0. Based on that we can calculate that during remaining 58 days it will total up to 130.0. Omeros stock expected interest is significantly higher compared to same quarter last year (+46.1%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 96 |
| 2019 | 196 104.2% QoQ | 205 4.6% QoQ | 200 -2.4% QoQ | 184 91.7% YoY -8.0% QoQ |
| 2020 | 233 18.9% YoY 26.6% QoQ | 248 21.0% YoY 6.4% QoQ | 397 98.5% YoY 60.1% QoQ | 369 100.5% YoY -7.1% QoQ |
| 2021 | 363 55.8% YoY -1.6% QoQ | 267 7.7% YoY -26.4% QoQ | 196 -50.6% YoY -26.6% QoQ | 281 -23.8% YoY 43.4% QoQ |
| 2022 | 181 -50.1% YoY -35.6% QoQ | 132 -50.6% YoY -27.1% QoQ | 125 -36.2% YoY -5.3% QoQ | 89 -68.3% YoY -28.8% QoQ |
| 2023 | 68 -62.4% YoY -23.6% QoQ | 137 3.8% YoY 101.5% QoQ | 121 -3.2% YoY -11.7% QoQ | 48 -46.1% YoY -60.3% QoQ |
The average 5 years interest of Omeros stock was 15.91 per week. The last year interest of Omeros stock compared to the last 5 years has changed by -47.39%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -43.71%.
After 39 days of this quarter the interest is at 85.0. Based on that we can calculate that during remaining 52 days it will total up to 198.0. Omeros news expected interest is significantly higher compared to previous quarter (+164.0%) and same quarter last year (+117.6%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 64 | 321 401.6% QoQ | 226 -29.6% QoQ | 126 -44.2% QoQ |
| 2020 | 106 65.6% YoY -15.9% QoQ | 82 -74.5% YoY -22.6% QoQ | 152 -32.7% YoY 85.4% QoQ | 42 -66.7% YoY -72.4% QoQ |
| 2021 | 90 -15.1% YoY 114.3% QoQ | 98 19.5% YoY 8.9% QoQ | 117 -23.0% YoY 19.4% QoQ | 227 440.5% YoY 94.0% QoQ |
| 2022 | 24 -73.3% YoY -89.4% QoQ | 17 -82.7% YoY -29.2% QoQ | 20 -82.9% YoY 17.6% QoQ | 100 -55.9% YoY 400.0% QoQ |
| 2023 | 91 279.2% YoY -9.0% QoQ | 26 52.9% YoY -71.4% QoQ | 110 450.0% YoY 323.1% QoQ | 75 -25.0% YoY -31.8% QoQ |
| 2024 | 85 -6.6% YoY 13.3% QoQ | - | - | - |
The average 5 years interest of Omeros news was 8.43 per week. The last year interest of Omeros news compared to the last 5 years has changed by -11.74%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -52.06%.
There is not enough data for Omeros pipeline to provide analysis
There is not enough data for Omeros pipeline to provide correlation calculation
There is not enough data for Omeros pipeline to provide analysis
There is not enough data for Omeros clinical trials to provide analysis
There is not enough data for Omeros clinical trials to provide correlation calculation
There is not enough data for Omeros clinical trials to provide analysis
There is not enough data for Omeros COVID-19 to provide analysis
There is not enough data for Omeros COVID-19 to provide correlation calculation
There is not enough data for Omeros COVID-19 to provide analysis
There is not enough data for Omeros MASP-2 to provide analysis
There is not enough data for Omeros MASP-2 to provide correlation calculation
There is not enough data for Omeros MASP-2 to provide analysis
There is not enough data for Omeros small-molecule inhibitors to provide analysis
There is not enough data for Omeros small-molecule inhibitors to provide correlation calculation
There is not enough data for Omeros small-molecule inhibitors to provide analysis
There is not enough data for Omeros protein therapeutics to provide analysis
There is not enough data for Omeros protein therapeutics to provide correlation calculation
There is not enough data for Omeros protein therapeutics to provide analysis